 Andrii Rozhok
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Evolution | 5 | 2019 | 415 | 1.890 |
Why?
| | Models, Biological | 5 | 2020 | 1647 | 1.770 |
Why?
| | Clonal Evolution | 2 | 2020 | 26 | 1.230 |
Why?
| | Hematopoietic Stem Cells | 4 | 2020 | 356 | 1.180 |
Why?
| | Carcinogenesis | 2 | 2019 | 177 | 1.100 |
Why?
| | Aging | 3 | 2019 | 1640 | 0.850 |
Why?
| | Mutation Rate | 2 | 2019 | 25 | 0.850 |
Why?
| | Neoplasms | 6 | 2019 | 2112 | 0.760 |
Why?
| | Cell Division | 3 | 2020 | 760 | 0.750 |
Why?
| | Body Size | 1 | 2019 | 92 | 0.650 |
Why?
| | Mutation | 6 | 2019 | 3370 | 0.600 |
Why?
| | Drosophila melanogaster | 3 | 2018 | 190 | 0.590 |
Why?
| | Stem Cells | 3 | 2019 | 543 | 0.590 |
Why?
| | DNA Transposable Elements | 3 | 2018 | 96 | 0.570 |
Why?
| | Models, Genetic | 1 | 2019 | 585 | 0.550 |
Why?
| | Leukemia | 1 | 2016 | 207 | 0.450 |
Why?
| | Cellular Senescence | 1 | 2014 | 153 | 0.440 |
Why?
| | Genome, Insect | 1 | 2012 | 14 | 0.420 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2014 | 312 | 0.420 |
Why?
| | Selection, Genetic | 3 | 2019 | 244 | 0.400 |
Why?
| | Neoplastic Stem Cells | 1 | 2014 | 330 | 0.380 |
Why?
| | Cell Lineage | 1 | 2012 | 311 | 0.360 |
Why?
| | Monte Carlo Method | 2 | 2019 | 140 | 0.330 |
Why?
| | Stochastic Processes | 2 | 2016 | 65 | 0.250 |
Why?
| | Animals | 11 | 2020 | 32123 | 0.230 |
Why?
| | Computer Simulation | 2 | 2019 | 887 | 0.220 |
Why?
| | Phenotype | 3 | 2019 | 2861 | 0.190 |
Why?
| | Age Factors | 2 | 2019 | 2912 | 0.180 |
Why?
| | Gamma Rays | 1 | 2020 | 47 | 0.180 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 72 | 0.180 |
Why?
| | Aneuploidy | 1 | 2020 | 86 | 0.170 |
Why?
| | Cellular Microenvironment | 1 | 2020 | 78 | 0.170 |
Why?
| | Discoidin Domain Receptor 2 | 1 | 2019 | 2 | 0.170 |
Why?
| | Bone Marrow Cells | 1 | 2020 | 272 | 0.170 |
Why?
| | Bone Marrow Transplantation | 1 | 2020 | 241 | 0.170 |
Why?
| | Population Density | 1 | 2019 | 95 | 0.160 |
Why?
| | Dasatinib | 1 | 2019 | 45 | 0.160 |
Why?
| | Urea | 1 | 2019 | 69 | 0.160 |
Why?
| | Longevity | 1 | 2019 | 137 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 153 | 0.150 |
Why?
| | Hematopoiesis | 1 | 2019 | 175 | 0.150 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 193 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2019 | 263 | 0.140 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 63 | 0.140 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2016 | 37 | 0.140 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2016 | 48 | 0.140 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2016 | 41 | 0.140 |
Why?
| | Carbazoles | 1 | 2016 | 80 | 0.140 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 102 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 301 | 0.130 |
Why?
| | Genetic Drift | 1 | 2015 | 7 | 0.130 |
Why?
| | Microtubule-Associated Proteins | 1 | 2016 | 176 | 0.130 |
Why?
| | Piperidines | 1 | 2016 | 163 | 0.130 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 15 | 0.130 |
Why?
| | Multipotent Stem Cells | 1 | 2015 | 18 | 0.130 |
Why?
| | Cell Survival | 2 | 2016 | 1026 | 0.120 |
Why?
| | Lung Neoplasms | 2 | 2019 | 2207 | 0.120 |
Why?
| | Immunotherapy | 1 | 2019 | 480 | 0.120 |
Why?
| | Radiation, Ionizing | 1 | 2015 | 73 | 0.120 |
Why?
| | Genetic Fitness | 1 | 2015 | 54 | 0.120 |
Why?
| | RNA Interference | 1 | 2016 | 438 | 0.120 |
Why?
| | Nonlinear Dynamics | 1 | 2015 | 89 | 0.120 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2016 | 225 | 0.120 |
Why?
| | Stem Cell Niche | 1 | 2014 | 43 | 0.120 |
Why?
| | Receptors, Notch | 1 | 2015 | 85 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2019 | 2196 | 0.120 |
Why?
| | Cell Line, Tumor | 5 | 2019 | 2749 | 0.120 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 686 | 0.110 |
Why?
| | Risk | 1 | 2016 | 830 | 0.110 |
Why?
| | Pyrazoles | 1 | 2016 | 362 | 0.110 |
Why?
| | Time Factors | 2 | 2015 | 6186 | 0.110 |
Why?
| | Pyridines | 1 | 2016 | 425 | 0.110 |
Why?
| | Adenoma | 1 | 2015 | 187 | 0.110 |
Why?
| | Humans | 11 | 2019 | 115907 | 0.110 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 555 | 0.110 |
Why?
| | Gene Transfer, Horizontal | 1 | 2012 | 25 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2016 | 638 | 0.100 |
Why?
| | Inflammation Mediators | 1 | 2015 | 481 | 0.100 |
Why?
| | Fibroblasts | 1 | 2016 | 838 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 964 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2016 | 532 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1548 | 0.090 |
Why?
| | Genotype | 1 | 2014 | 1842 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1001 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 733 | 0.080 |
Why?
| | Mice | 3 | 2020 | 15075 | 0.080 |
Why?
| | Signal Transduction | 3 | 2019 | 4526 | 0.080 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1045 | 0.080 |
Why?
| | Phylogeny | 1 | 2012 | 802 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2015 | 3916 | 0.080 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 617 | 0.080 |
Why?
| | DNA Methylation | 1 | 2012 | 498 | 0.070 |
Why?
| | Cytokines | 1 | 2015 | 1857 | 0.070 |
Why?
| | Ukraine | 2 | 2018 | 10 | 0.070 |
Why?
| | Female | 5 | 2020 | 60086 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2016 | 1870 | 0.060 |
Why?
| | Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2019 | 5 | 0.040 |
Why?
| | Cell Respiration | 1 | 2019 | 74 | 0.040 |
Why?
| | Hybridization, Genetic | 1 | 2018 | 77 | 0.040 |
Why?
| | Glycolysis | 1 | 2019 | 222 | 0.040 |
Why?
| | Fertility | 1 | 2018 | 131 | 0.040 |
Why?
| | Genetics, Population | 1 | 2018 | 203 | 0.040 |
Why?
| | Child | 1 | 2016 | 18555 | 0.040 |
Why?
| | Hydrazines | 1 | 2016 | 28 | 0.030 |
Why?
| | Benzothiazoles | 1 | 2016 | 33 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 604 | 0.030 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 83 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 376 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2019 | 557 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2016 | 562 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2016 | 546 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2016 | 703 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 536 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 376 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 961 | 0.030 |
Why?
| | Mitochondria | 1 | 2019 | 753 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2016 | 933 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1221 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2655 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 2012 | 55 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3342 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2016 | 789 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1033 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1319 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 2606 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 1707 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2015 | 3054 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 1891 | 0.020 |
Why?
| | Middle Aged | 2 | 2016 | 27084 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 4769 | 0.020 |
Why?
| | Cohort Studies | 1 | 2015 | 4960 | 0.020 |
Why?
| | Prospective Studies | 1 | 2015 | 6267 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 9166 | 0.010 |
Why?
| | Aged | 1 | 2015 | 19299 | 0.010 |
Why?
| | Male | 1 | 2015 | 56128 | 0.010 |
Why?
|
|
Rozhok's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|